Latest from NIDA | National Institute on Drug Abuse (NIDA)

Expression of a Gene in the Brain Links Nicotine Addiction to Diabetes

May 12, 2020 | Rats with a disrupted transcription factor 7-like 2 (Tcf7l2) gene in the medial habenula showed markedly greater nicotine intake than control rats. Reduced Tcf7l2 expression in the medial habenula reduced...

Announcement

NIDA launches drug education booklet series for middle school students

May 1, 2020 | The National Institute on Drug Abuse (NIDA) has launched a redesigned series of booklets geared towards educating middle school students about substance use. The Mind Matters series consists of nine...

Science Highlight

Learning how to disrupt cocaine’s effects on the brain

April 20, 2020 | Just published research by scientists at NIDA’s Intramural Research Program reveals that the drug cocaine causes neurons to synthesize endocannabinoids that are then enclosed within membrane-bound packages, known as extracellular...

News Release

Landmark study of adolescent brain development renews for additional seven years

April 15, 2020 | With nearly $290M of new funding for seven years to research institutions around the country, the National Institutes of Health renewed its commitment to the Adolescent Brain Cognitive Development (ABCD)...

Science Highlight

Dopamine found to play unexpected role in cocaine withdrawal

April 13, 2020 | This study has linked cocaine withdrawal to altered gene expression in a brain region affected by addiction.

NIDA Notes

Mu Opioid Receptors in One Brain Region Contribute to Naloxone Aversion

April 9, 2020 | Mice genetically engineered to lack mu opioid receptors in the medial habenula were less sensitive to the unpleasant effects of the opioid antagonist naloxone and showed fewer naloxone-induced withdrawal symptoms.

Science Highlight

Marijuana vaping and edible use increasing among high school seniors

April 6, 2020 | A new analysis suggests that among adolescent marijuana users, smoking has become less prevalent, eclipsed by vaping and edibles.

Announcement

NIDA Director outlines potential risks to people who smoke and use drugs during COVID-19 pandemic

April 2, 2020 | The precarious intersection of the COVID-19 national health emergency and the concurrent epidemic of drug overdose deaths is outlined in the Annals of Internal Medicine this week by Dr. Nora...

Announcement

Stigma and addiction addressed in New England Journal of Medicine

April 2, 2020 | In a perspective released today in The New England Journal of Medicine, NIDA Director Dr. Nora Volkow addresses how stigma against people who use drugs can sabotage effective treatment.

NIDA Notes

Many People Treated for Opioid Overdose in Emergency Departments Die Within 1 Year

April 2, 2020 | About 1 in 20 patients treated for a nonfatal opioid overdose in an emergency department died within 1 year of their visit, many within 2 days. Two-thirds of these deaths...

Science Highlight

Dopamine Neurons Signal Rich Information About Unexpected Events

March 27, 2020 | In this study, both rats and humans learned to predict differently flavored rewards in parallel choice tasks, showing that dopamine neurons are carrying much more information than previously thought.

NIDA Notes

Stronger Brain Circuit Connectivity May Predict Nicotine Dependence Severity

March 25, 2020 | The degree of connectivity of a neuronal network in the rat brain before nicotine exposure can help predict nicotine dependence severity after nicotine exposure as well as reversal of dependence...

Science Highlight

New biological clues linking social connectedness to reduced drug craving and relapse

March 24, 2020 | This rodent study offers the first mechanistic explanation for the protective effect of social interaction related to incubation of craving, showing for the first time the role of a specific...

News Release

National Drug and Alcohol Facts Week® celebrates 10 years

March 23, 2020 | NDAFW is an annual, week-long observance in which local educational events link teens with science-based facts about drugs and alcohol through live and online activities across the country.

Emerging Trend

COVID-19 is an Emerging, Rapidly Evolving Situation

March 18, 2020 | Links to the latest resources on COVID-19

NIDA Notes

Serotonin Receptor Agonist Lorcaserin Reduces Relapse to Drug Use in Monkeys

March 10, 2020 | The serotonin 2C receptor agonist lorcaserin reduced reinstatement of drug-seeking behavior in response to heroin or cocaine in a nonhuman primate model of relapse.

NIDA Notes

E-Cigarette Characteristics May Influence Use and Are Potential Targets for Regulatory Policy

March 2, 2020 | People's decisions to use e-cigarettes, as well as perceptions about associated risks, are influenced by the e-cigarettes' nicotine levels and available flavors. The influence of these characteristics on decision-making and...

Science Highlight

Study highlights effectiveness of methadone and buprenorphine

February 28, 2020 | In a comparative effectiveness study of 6 approaches to treatment for opioid use disorders, only treatment with buprenorphine or methadone was associated with reduced risk of overdose and serious opioid-related...

Science Highlight

NIDA scientists: Blocking adenosine receptors should counteract adverse effects of cannabinoids

February 21, 2020 | Computational modeling by NIDA scientists suggests the possible use of adenosine A2A receptor antagonists to counteract the adverse effects of cannabinoids.

Science Highlight

Babies exposed to HCV not adequately tested

February 18, 2020 | NIDA-funded science has found that HCV exposed infants might not be commonly or adequately tested.

NIDA Notes

Antiretroviral Therapy Combined With CRISPR Gene Editing Can Eliminate HIV Infection in Mice

February 14, 2020 | This study found that HIV-1 could be eliminated in mice using a combination of two antiviral technologies—long-acting viral reservoir—targeted antiretroviral therapy and CRISPR/Cas-9 gene editing. HIV was undetectable in 9...

Science Highlight

Many teens who overdose on opioids do not get effective follow-up

February 5, 2020 | An analysis of Medicaid records shows that less than one-third of youths treated for a nonfatal opioid overdose received timely follow-up treatment, and only 1 in 54 youths received recommended...

NIDA Notes

Part 2: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

| En español

February 5, 2020 | Researchers move their monoclonal antibody (mAb) into clinical trials to see if it can be an effective treatment for methamphetamine use.

NIDA Notes

Part 1: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

| En español

January 30, 2020 | Researchers have created a monoclonal antibody (mAb) that is intended to interact with methamphetamine and decrease its ability to enter the brain.

Science Highlight

Coaxing the brain to pay attention to healthier choices

January 30, 2020 | Neuroscience research from NIDA’s Intramural Research Program suggests that cortical mechanisms, especially in the orbitofrontal cortex, are likely involved in attentional bias to cocaine associated environmental cues and offer a...

NIDA Notes

AOUD Treatment in Primary Care Settings—Is it Feasible?

January 21, 2020 | Treatment for alcohol and opioid use disorders (AOUD) is feasible in primary care settings, but ongoing funding to support organizational capacity is critical for sustaining such programs.

Testimony

Hearing on Cannabis Policies for the New Decade

January 15, 2020 | Chairwoman Eshoo, Ranking Member Burgess, and members of the Subcommittee, thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH)...

NIDA Notes

A New Era at NIDA Notes

January 14, 2020 | As we enter a new year, we would like to honor and thank NIDA Notes Editor David Anderson, who recently retired after 20 years at the helm of NIDA’s signature...

NIDA Notes

Novel Dopamine D3 Receptor Antagonist Reduces Opioid Addiction-Like Behaviors in Rats

| En español

January 13, 2020 | The dopamine D3 receptor antagonist VK4-116 reduced oxycodone self-administration in rats, as well as drug-seeking behaviors after oxycodone reinstatement following withdrawal. VK4-116 did not interfere with oxycodone’s pain-relieving effects

Science Highlight

Changing the way we view opioid receptors

January 9, 2020 | Newly published research from NIDA funded scientists offers new insight into how opioid receptors work to regulate chemical communication in the brain. The researchers discover unexpected receptor mobility and diffusion...